APA (7th ed.) Citation

RC, B., R, A., RR, S., PD, R., SE, F., AR, K., . . . E, K. (2023). Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin-Deficient Diabetic Mice. JBMR plus, 7(11), e10833. https://doi.org/10.1002/jbm4.10833

Chicago Style (17th ed.) Citation

RC, Bunn, et al. "Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin-Deficient Diabetic Mice." JBMR Plus 7, no. 11 (2023): e10833. https://doi.org/10.1002/jbm4.10833.

MLA (9th ed.) Citation

RC, Bunn, et al. "Pharmacologic Inhibition of Myostatin With a Myostatin Antibody Improves the Skeletal Muscle and Bone Phenotype of Male Insulin-Deficient Diabetic Mice." JBMR Plus, vol. 7, no. 11, 2023, p. e10833, https://doi.org/10.1002/jbm4.10833.